Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Mar 5

PMID 33665190

Citations 51

Authors

Adrienne Wright

Marne L Arthaud-Day

Mark L Weiss

Affiliations

Soon will be listed here.

Abstract

Following their discovery over 50 years ago, mesenchymal stromal cells (MSCs) have become one of the most studied cellular therapeutic products by both academia and industry due to their regenerative potential and immunomodulatory properties. The promise of MSCs as a therapeutic modality has been demonstrated by preclinical data yet has not translated to consistent, successful clinical trial results in humans. Despite the disparities across the field, MSC shareholders are unified under one common goal-to use MSCs as a therapeutic modality to improve the quality of life for those suffering from a malady in which the standard of care is suboptimal or no longer effective. Currently, there is no Food and Drug Administration (FDA)-approved MSC therapy on the market in the United States although several MSC products have been granted regulatory approval in other countries. In this review, we intend to identify hurdles that are impeding therapeutic progress and discuss strategies that may aid in accomplishing this universal goal of widespread therapeutic use.

Citing Articles

Therapeutic effect of long-interval repeated subcutaneous administration of canine amniotic membrane-derived mesenchymal stem cells in atopic dermatitis mouse model.

Kim M, Kong D, Kim N, Kim M, Kim H, Choi J BMC Vet Res. 2025; 21(1):115.

PMID: 40011929 PMC: 11866708. DOI: 10.1186/s12917-025-04554-w.

Identifying differentiation markers between dermal fibroblasts and adipose-derived mesenchymal stromal cells (AD-MSCs) in human visceral and subcutaneous tissues using single-cell transcriptomics.

Koczkowska M, Kostecka A, Zawrzykraj M, Myszczynski K, Skoniecka A, Deptula M Stem Cell Res Ther. 2025; 16(1):64.

PMID: 39934849 PMC: 11818286. DOI: 10.1186/s13287-025-04185-w.

Rabbit visceral adipose stromal cell reveals phenotype and genotype characteristics of adult mesenchymal stem cell.

Aswin A, Susilowati H, Yudaniayanti I, Susanti L, Diyantoro D, Rodprasert W Open Vet J. 2025; 14(12):3317-3326.

PMID: 39927335 PMC: 11799644. DOI: 10.5455/OVJ.2024.v14.i12.16.

Secretome from hypoxic mesenchymal stem cells as a potential therapy for ischemic stroke: Investigations on and expression.

Silvana S, Japardi I, Rusda M, Daulay R, Putra A, Mangunatmadja I Narra J. 2025; 4(3):e1181.

PMID: 39816066 PMC: 11732002. DOI: 10.52225/narra.v4i2.1181.

Clinical-grade extracellular vesicles derived from umbilical cord mesenchymal stromal cells: preclinical development and first-in-human intra-articular validation as therapeutics for knee osteoarthritis.

Figueroa-Valdes A, Luz-Crawford P, Herrera-Luna Y, Georges-Calderon N, Garcia C, Tobar H J Nanobiotechnology. 2025; 23(1):13.

PMID: 39806427 PMC: 11730155. DOI: 10.1186/s12951-024-03088-x.

References

Screven R, Kenyon E, Myers M, Yancy H, Skasko M, Boxer L . Immunophenotype and gene expression profile of mesenchymal stem cells derived from canine adipose tissue and bone marrow. Vet Immunol Immunopathol. 2014; 161(1-2):21-31. DOI: 10.1016/j.vetimm.2014.06.002. View

Kern S, Eichler H, Stoeve J, Kluter H, Bieback K . Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells. 2006; 24(5):1294-301. DOI: 10.1634/stemcells.2005-0342. View

Yang Y, Hu M, Zhang Y, Li H, Miao Z . CD29 of human umbilical cord mesenchymal stem cells is required for expansion of CD34(+) cells. Cell Prolif. 2014; 47(6):596-603. PMC: 6495839. DOI: 10.1111/cpr.12130. View

Rojewski M, Lotfi R, Gjerde C, Mustafa K, Veronesi E, Ahmed A . Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data. Cytotherapy. 2019; 21(4):468-482. DOI: 10.1016/j.jcyt.2019.03.001. View

Zhang S, Zhao C, Liu S, Wang Y, Zhao Y, Guan W . Characteristics and multi‑lineage differentiation of bone marrow mesenchymal stem cells derived from the Tibetan mastiff. Mol Med Rep. 2018; 18(2):2097-2109. PMC: 6072167. DOI: 10.3892/mmr.2018.9172. View

Melsheimer R, Calmann M, DeRitis A, Philip V, Van Gog F, Doolittle L . Ensuring Product Quality, Consistency and Patient Supply over Time for a Large-Volume Biologic: Experience with Remicade. BioDrugs. 2018; 32(5):405-414. PMC: 6182491. DOI: 10.1007/s40259-018-0300-7. View

Crain S, Robinson S, Thane K, Davis A, Meola D, Barton B . Extracellular Vesicles from Wharton's Jelly Mesenchymal Stem Cells Suppress CD4 Expressing T Cells Through Transforming Growth Factor Beta and Adenosine Signaling in a Canine Model. Stem Cells Dev. 2018; 28(3):212-226. DOI: 10.1089/scd.2018.0097. View

FRIEDENSTEIN A, PETRAKOVA K, Kurolesova A, Frolova G . Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968; 6(2):230-47. View

Ahmed M, Ghabriel M, Amleh A . Enrichment, Propagation, and Characterization of Mouse Testis-Derived Mesenchymal Stromal Cells. Cell Reprogram. 2017; 19(1):35-43. DOI: 10.1089/cell.2016.0022. View

10.

Mendicino M, Bailey A, Wonnacott K, Puri R, Bauer S . MSC-based product characterization for clinical trials: an FDA perspective. Cell Stem Cell. 2014; 14(2):141-5. DOI: 10.1016/j.stem.2014.01.013. View

11.

Danisovic L, Varga I, Polak S, Ulicna M, Hlavackova L, Bohmer D . Comparison of in vitro chondrogenic potential of human mesenchymal stem cells derived from bone marrow and adipose tissue. Gen Physiol Biophys. 2009; 28(1):56-62. View

12.

Sobh M . Adipogenesis of Sprague Dawely rats mesenchymal stem cells: a morphological, immunophenotyping and gene expression follow-up study. Anat Cell Biol. 2014; 47(2):83-90. PMC: 4076425. DOI: 10.5115/acb.2014.47.2.83. View

13.

Jeong S, Ji Y, Yoon E . Immunosuppressive activity of adipose tissue-derived mesenchymal stem cells in a rat model of hind limb allotransplantation. Transplant Proc. 2014; 46(5):1606-14. DOI: 10.1016/j.transproceed.2013.12.069. View

14.

Lukomska B, Stanaszek L, Zuba-Surma E, Legosz P, Sarzynska S, Drela K . Challenges and Controversies in Human Mesenchymal Stem Cell Therapy. Stem Cells Int. 2019; 2019:9628536. PMC: 6481040. DOI: 10.1155/2019/9628536. View

15.

Tanavde V, Vaz C, Rao M, Vemuri M, Pochampally R . Research using Mesenchymal Stem/Stromal Cells: quality metric towards developing a reference material. Cytotherapy. 2015; 17(9):1169-77. PMC: 4943322. DOI: 10.1016/j.jcyt.2015.07.008. View

16.

Rui Y, Lui P, Li G, Fu S, Lee Y, Chan K . Isolation and characterization of multipotent rat tendon-derived stem cells. Tissue Eng Part A. 2009; 16(5):1549-58. DOI: 10.1089/ten.TEA.2009.0529. View

17.

Ranera B, Lyahyai J, Romero A, Vazquez F, Remacha A, Bernal M . Immunophenotype and gene expression profiles of cell surface markers of mesenchymal stem cells derived from equine bone marrow and adipose tissue. Vet Immunol Immunopathol. 2011; 144(1-2):147-54. DOI: 10.1016/j.vetimm.2011.06.033. View

18.

Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P . Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev. 2008; 17(4):761-73. DOI: 10.1089/scd.2007.0217. View

19.

Hosseinzadeh Shirzeily M, Pasbakhsh P, Amidi F, Mehrannia K, Sobhani A . Comparison of differentiation potential of male mouse adipose tissue and bone marrow derived-mesenchymal stem cells into germ cells. Iran J Reprod Med. 2014; 11(12):965-76. PMC: 3941408. View

20.

Carvalho A, Alves A, Golim M, Moroz A, Hussni C, de Oliveira P . Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue. Vet Immunol Immunopathol. 2009; 132(2-4):303-6. DOI: 10.1016/j.vetimm.2009.06.014. View